Charles River Laboratories | CRL - 员工 总数



金融业
股票价格
USD
资产
USD 7.73B
现金及等价物
USD 191.83M
销售成本
USD 716.51M
流动资产
USD 1.49B
流动负债
USD 1.09B
债务
USD 2.57B
EBIT
USD 119.9M
EBITDA
USD 229.8M
员工
18.6K
EPS每股收益
USD 2.06
股本和储备
USD 2.9B
销售毛利
USD 279.32M
债务利息支出
USD 26.74M
利息收入
USD -0.3
贷款资金
USD 2.66B
市值
USD 9.43B
净收入
USD -14.84M
营业费用
USD 875.93M
营业利润
USD 119.9M
普通股股本
USD 48.17M
PE价格收益
29.27
税前利润
USD -294.1M
销售收入
USD 995.8M
销售和管理费用
USD 159.42M
股票
USD 359.72M
贸易债权人
USD 133.95M
应收帐款人
USD 700.25M


员工 更改 日
Agilent 17.9K 200 2024-10
Align Technology 20.94K 665 2024-12
Bio-Rad Laboratories 8.03K 170 2023-12
Bruker 9.71K 1.18K 2023-12
Cardinal Health 57.7K 8.8K 2025-12
Charles River Laboratories 18.6K 1.4K 2024-12
Cigna 73.5K 1000 2024-12
Concord Medical Services Hldg CNY 918 54 2022-12
CVS Health 300K 0 2024-12
Danaher 61K 18K 2023-12
Dentsply International 14K 1000 2024-12
Elevance Health 104.9K 2.6K 2023-12
Humana 65.68K 1.92K 2024-12
Illumina 8.97K 1.62K 2024-12
Incyte 2.62K 93 2024-12
Intrexon 202 7 2023-12
IQVIA Holdings 88K 1000 2024-12
Laboratory Of America 70K 3K 2024-12
Lakefront Biotherapeutics 1.34K 29 2022-12
Lonza 17.49K 1.28K 2022-12
McKesson 45K 13K 2023-03
Merck 64.23K 3.9K 2022-12
Mettler Toledo International 16K 400 2023-12
Novartis USD 101.7K 2.62K 2022-12
Pfizer 81K 7K 2024-12
Quest Diagnostics 40K 0 2023-12
Revvity 11K 500 2024-12
Thermo Fisher Scientific 125K 3K 2024-12
United Therapeutics 1.3K 137 2024-12
UnitedHealth 400K 40K 2024-12
Veradigm 8K 400 2021-12
Waters 7.6K 300 2024-12
West Pharmaceutical Services 10.6K 0 2024-12